Lifecoach: Life After Breast Cancer - Impact of a Life Coach

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05020561
Collaborator
Quebec Breast Cancer Foundation (Other)
120
1
3
23.5
5.1

Study Details

Study Description

Brief Summary

The objectives of our intervention are to

  1. Ease the transition between cancer treatment and active life, and

  2. Allow breast cancer survivors to take control of their lives.

The primary objective of this study is to:
  1. Determine whether individual life coaching (i.e., individualized guidance that helps to put resources into action) can significantly improve quality of life and post-traumatic growth among women who have been recently treated with breast cancer.
It is hypothesized that:
  1. Participants who receive both "group coaching sessions" and "individualized coaching sessions" will report greater post-traumatic growth and quality of life, and less fear of cancer recurrence when compared to the breast cancer survivors who received only the group coaching sessions or usual care.

  2. Participants who receive only the group coaching sessions will report greater post-traumatic growth and quality of life, and lesser fear of cancer recurrence when compared to the participants who receive usual care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Group life-coaching
  • Behavioral: Individual life-coaching
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Adjustment to Life After Breast Cancer Treatment: Can a Life-Coach Make a Difference
Anticipated Study Start Date :
Sep 15, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm 1 - Group and Individual

Participants in this experimental Arm 1 will receive the 3 group sessions followed by 4 to 5 individual coaching sessions via phone calls that last 60 minutes each.

Behavioral: Group life-coaching
Group coaching sessions will be focusing on providing material and tools that guide the participants in the transition from cancer treatment to survivorship. All activities of the group session will be following the "After Cancer Passport" document.

Behavioral: Individual life-coaching
In the individual coaching sessions, the life-coach will provide guidances that help the participants to put tools into actions. All activities are outlined in the After Cancer Passport. Participants will use their Passport for each individual coaching session to outline their objectives and indicators of success. The life coach will also assign activities, such as self-reflection, for the participants to complete between each session.

Experimental: Arm 2 - Group only

Arm 2 will receive only the first 3 Life coach sessions (group session).

Behavioral: Group life-coaching
Group coaching sessions will be focusing on providing material and tools that guide the participants in the transition from cancer treatment to survivorship. All activities of the group session will be following the "After Cancer Passport" document.

No Intervention: Arm 3 - Routine care

Arm 3 will receive routine care by the Breast clinic team for the entire course of the study.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline Post-traumatic growth (PTG) assessed by the Post-Traumatic Growth Inventory (PTGI) [12 months]

    The PTGI consists of 21 items, the response scale is a 6-point Likert scale asking respondents the degree to which changes occurred in their lives as a result of the crisis, where 0 represented "I did not experience this change" and 5 represented "I experienced this change to a very great degree". The PTGI is composed of 5 subscales, with 5 items measuring the construct New Possibilities, 7 items measuring the construct Relating to Others, 4 items measuring the construct Personal Strength, 3 items measuring the construct Appreciation of Life and 2 items measuring the construct Spiritual Change. The scores are summed to provide an overall measure of post-traumatic growth ranging from 0 - 105 where higher scores indicate more reported growth.

Secondary Outcome Measures

  1. Change from baseline Fear of cancer recurrence (FCR) assessed by the Cancer Worry Scale (CWS) [12 months]

    The CWS is a six-item scale designed to measure worry about the risk of developing cancer and the impact of worry on daily functioning. The six items are rated on a 4-point Likert scale ranging from 1 ("never") to 4 ("almost always"). Possible scores range from 6 to 24 with higher scores indicating more worry.

  2. Change from baseline Quality of life (QoL) assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS)-Preference [12 months]

    The PROPr is a 31-item instrument assessing eight domains (29 items) (i.e., anxiety, depression, fatigue, pain interference, physical function, sleep disturbance, ability to participate in social roles and activities, and pain intensity), and Cognitive Function Abilities (2 items). Raw scores generated for each domain are transformed into T scores; higher PROMIS T scores indicate greater endorsement of the construct being assessed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. have been diagnosed with stage I, II, or III breast cancer;

  2. are female breast cancer patients over the age of 18;

  3. have completed anti-cancer treatment via surgery and/or chemotherapy and /or radiation therapy at the McGill University Health Centre Breast Clinic;

  4. are fluent in written and spoken English or French;

  5. are alert and oriented and capable of giving informed consent;

  6. have an Internet connection at home that supports participation in coaching sessions via videoconferencing (zoom).

Exclusion Criteria:
  1. have a recurrence of breast cancer;

  2. are diagnosed with a second cancer;

  3. are diagnosed with stage IV breast cancer due to their worse prognosis; and 4) have an active psychiatric diagnosis that would render adherence to the study problematic.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cedar's Breast Clinic, Royal Victoria Hospital Montreal Quebec Canada H3G 1A4

Sponsors and Collaborators

  • McGill University Health Centre/Research Institute of the McGill University Health Centre
  • Quebec Breast Cancer Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Sarkis Meterissian, Principal Investigator, McGill University Health Centre/Research Institute of the McGill University Health Centre
ClinicalTrials.gov Identifier:
NCT05020561
Other Study ID Numbers:
  • 2022-7735
First Posted:
Aug 25, 2021
Last Update Posted:
Aug 25, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Sarkis Meterissian, Principal Investigator, McGill University Health Centre/Research Institute of the McGill University Health Centre
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 25, 2021